Activity content starts in:
Industry Webcast
At the heart of reducing CV risks in adult patients with CKD and T2DIndustry Webcast Sponsored by Bayer U.S. Pharmaceutical; Not for CME/CE Credit
Persistently elevated albuminuria increases the risk of cardiovascular (CV) complications for patients with Type 2 Diabetes and Chronic Kidney Disease. That’s why timely intervention is essential for reducing the risk of CV death, non-fatal myocardial infarction and hospitalization for heart failure. Join us as we underscore the major role Primary Care Physicians play for these patients and how they can assess CV risk using the KDIGO (Kidney Disease: Improving Global Outcomes) CV Mortality Risk Heat Map.
CME/CE Information
0 Credits - Not for CME/CE Credit
Release Date: 6/9/2026
Expiration Date: 6/9/2026
Topics
Faculty
Faculty
Christian W. Mende, MD
Learn MoreSupporters and Partners
Industry Sponsor
Bayer U.S.
Fine Print
The preferred browser is Google Chrome. If using a different browser, such as Safari, Firefox or Edge, make sure you are using the most up-to-date version. Your Internet settings should be set to accept cookies and JavaScript. If cookies and/or JavaScript are disabled, the site may not function properly. A high-speed Internet connection is not required; however, it is recommended for faster download times.